The Drug Repurposing for COVID-19 Clinical Trials Provide Very Effective Therapeutic Combinations: Lessons Learned From Major Clinical Studies

SARS-CoV-2 has spread across the globe in no time. In the beginning, people suffered due to the absence of efficacious drugs required to treat severely ill patients. Nevertheless, still, there are no established therapeutic molecules against the SARS-CoV-2. Therefore, repurposing of the drugs starte...

Descripción completa

Detalles Bibliográficos
Autores principales: Chakraborty, Chiranjib, Sharma, Ashish Ranjan, Bhattacharya, Manojit, Agoramoorthy, Govindasamy, Lee, Sang-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636940/
https://www.ncbi.nlm.nih.gov/pubmed/34867318
http://dx.doi.org/10.3389/fphar.2021.704205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636940/
https://www.ncbi.nlm.nih.gov/pubmed/34867318
http://dx.doi.org/10.3389/fphar.2021.704205

Ejemplares similares